West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 2,146,900 | 1,839,900 | 1,717,400 | 1,599,100 | 1,509,100 |
| Cost of Goods | 1,379,100 | 1,234,200 | 1,172,000 | 1,086,200 | 1,007,700 |
| Gross Profit | 767,800 | 605,700 | 545,400 | 512,900 | 501,400 |
| Operating Expenses | 361,000 | 309,300 | 305,100 | 287,300 | 306,900 |
| Operating Income | 406,900 | 296,600 | 240,300 | 225,800 | 195,200 |
| Interest Expense | 8,200 | 8,500 | 8,400 | 7,800 | 8,100 |
| Other Income | 20,000 | 12,600 | 16,400 | 13,600 | 10,900 |
| Pre-tax Income | 418,700 | 300,700 | 248,300 | 231,600 | 198,000 |
| Income Tax | 72,500 | 59,000 | 41,400 | 80,900 | 54,400 |
| Net Income Continuous | 346,200 | 241,700 | 206,900 | 150,700 | 143,600 |
| Net Income | $346,200 | $241,700 | $206,900 | $150,700 | $143,600 |
| EPS Basic Total Ops | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 |
| EPS Basic Continuous Ops | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 |
| EPS Diluted Total Ops | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 |
| EPS Diluted Continuous Ops | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 |
| EPS Diluted Before Non-Recurring Items | 4.76 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $516,000 | $400,000 | $344,700 | $322,500 | $285,900 |